LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 108 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,386,958 | -12.7% | 2,022,846 | +4.3% | 0.00% | – |
| Q2 2023 | $2,733,584 | +316.5% | 1,938,712 | +343.1% | 0.00% | – |
| Q1 2023 | $656,244 | -35.9% | 437,496 | -50.0% | 0.00% | – |
| Q4 2022 | $1,023,740 | +106.0% | 874,992 | +98.8% | 0.00% | – |
| Q3 2022 | $497,000 | -28.5% | 440,096 | 0.0% | 0.00% | – |
| Q2 2022 | $695,000 | -78.6% | 440,096 | -79.1% | 0.00% | – |
| Q1 2022 | $3,242,000 | -36.2% | 2,105,107 | +1.5% | 0.00% | – |
| Q4 2021 | $5,082,000 | -63.1% | 2,074,234 | -62.0% | 0.00% | -100.0% |
| Q3 2021 | $13,755,000 | +158.4% | 5,458,451 | +192.2% | 0.00% | – |
| Q2 2021 | $5,324,000 | +3357.1% | 1,868,046 | +2745.3% | 0.00% | – |
| Q1 2021 | $154,000 | +51.0% | 65,654 | +12.9% | 0.00% | – |
| Q4 2020 | $102,000 | +88.9% | 58,154 | 0.0% | 0.00% | – |
| Q3 2020 | $54,000 | +5.9% | 58,154 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | -96.5% | 58,154 | -96.7% | 0.00% | – |
| Q1 2020 | $1,452,000 | -9.2% | 1,753,991 | -2.4% | 0.00% | – |
| Q4 2019 | $1,600,000 | -7.9% | 1,797,923 | +1.4% | 0.00% | – |
| Q3 2019 | $1,738,000 | – | 1,773,907 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $40,874,517 | 3.42% |
| Defender Capital, LLC. | 5,093,535 | $5,959,436 | 2.41% |
| Raffles Associates | 1,536,946 | $1,798,230 | 2.10% |
| Prescott General Partners LLC | 1,851,851 | $2,166,666 | 0.18% |
| DAFNA Capital Management LLC | 140,000 | $163,800 | 0.05% |
| Fort Sheridan Advisors LLC | 83,931 | $98,199 | 0.03% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $52,650 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $914,666 | 0.02% |
| ETF MANAGERS GROUP, LLC | 353,991 | $414,169 | 0.02% |
| Straight Path Wealth Management | 16,200 | $18,954 | 0.02% |